M&A Deal Summary

KKR Acquires Frontier Biosolutions

On October 16, 2023, private equity firm KKR acquired life science company Frontier Biosolutions

Acquisition Highlights
  • This is KKR’s 20th transaction in the Life Science sector.
  • This is KKR’s 196th transaction in the United States.
  • This is KKR’s 17th transaction in New York.

M&A Deal Summary
Date 2023-10-16
Target Frontier Biosolutions
Sector Life Science
Buyer(s) KKR
Deal Type Consolidation

Target

Frontier Biosolutions

New York, New York, United States
Frontier Biosolutions is a global pharma services platform. Frontier Biosolutions is based in New York.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

KKR

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1976
PE ASSETS 267.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION
KKR's office in Menlo Park, California.
KKR's office in Menlo Park, California.

KKR is a global investment firm founded by Jerome Kohlberg, Henry Kravis, and George Roberts. The Firm is separated into several business segments including private markets, public markets, capital markets, and other principal activities. KKR's private equity practice invests in management buyouts, take privates, corporate divestitures, industry consolidations, and partnerships with family-owned companies. KKR will invest in a broad range of industries and companies and will consider businesses throughout North America, Europe, Asia, and Australia/New Zealand. Sectors of interest include chemicals, consumer products, energy and natural resources, financial services, healthcare, industrial, media/communications, retail, and technology. In addition to its traditional principal investment activity business, KKR also invests in infrastructure assets. KKR was formed in 1976 and is based in New York, New York.

DEAL STATS #
Overall 461 of 483
Sector (Life Science) 20 of 20
Type (Consolidation) 11 of 11
State (New York) 17 of 19
Country (United States) 196 of 210
Year (2023) 14 of 18
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-09-27 Slayback Pharma

Princeton, New Jersey, United States

Slayback Pharma is a specialty pharmaceutical company focused on developing, manufacturing, and sourcing complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. Slayback Pharma was founded in 2011 and is based in Princeton, New Jersey.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-10-24 Precipart

Farmingdale, New York, United States

Precipart is a contract development and manufacturing organization of highly engineered precision components and assemblies, primarily for the medical device industry as well as the aerospace and industrial markets. Precipart is based in Farmingdale, New York.

Buy -
Mergr

Product

Company

Legal